Henry Brem - 12 Mar 2026 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
12 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 09:46:55 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brem Henry Director 4960 PEACHTREE INDUSTRIAL BLVD, SUITE 240, NORCROSS Jack W. Callicutt, by power of attorney 17 Mar 2026 0001387877

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GALT Stock option (right to buy) Award +60,000 $0.000000* 60,000 12 Mar 2026 Common Stock 60,000 $3.16 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
F2 The options vest 100% on December 31, 2026.